相关实验视频
Updated: Jun 18, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
在萨斯喀彻温省老龄化人口中的多病症和住院治疗的区域模式
Udoka Okpalauwaekwe1, Masud Rana1, Huey-Ming Tzeng2
1Department of Family Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 2Z4, Canada.
Healthcare (Basel, Switzerland)
|January 28, 2026
概括
多病症,即多种慢性疾病的同时发生,在萨斯喀彻温省,特别是北部地区,不成比例地影响着老年人. 这种健康差异与较差的健康结果和医疗保健使用量的增加有关,需要有针对性的干预措施.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 老年人群中的多病症正在上升,影响健康和医疗保健利用.
- 多发病率存在区域差异,但省级数据有限,如萨斯喀彻温省.
- 了解多病症的模式对于解决医疗保健准入和急性护理需求至关重要.
研究的目的:
- 在萨斯喀彻温省的老年成人人口中绘制多病症的社会人口和地理模式.
- 调查多病症与获得医疗保健,未满足的需求和急性护理利用 (ED访问,住院治疗) 之间的关联.
主要方法:
- 基于人口的电话调查对1093名65岁以上的萨斯喀彻温成年人进行了二次分析.
- 根据慢性疾病负担对受访者进行分类:没有,一个或多病.
- 描述性统计和邮政编码级地图绘制以分析健康状况,获取和利用.
主要成果:
- 在老年人 (75岁以上),土著受访者和低学历者中,多发病率 (10.6%) 较高.
- 多种疾病与自我评估的健康状况较差,未满足的需求增加,急救诊所访问率较高 (20.7%) 和住院率较高 (12.1%).
- 北萨斯喀彻温州的多病发病率较高,尽管人口较小.
结论:
- 在萨斯喀彻温省的老年人中,慢性疾病负担存在显著的社会和空间差异.
- 调查结果强调需要在农村和北萨斯喀彻温省以公平为重点的医疗保健战略.
- 解决多病症需要根据地理和社会经济因素考虑量身定制的方法.
相关概念视频
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Hospitals-II
Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in hospitals have...
Nurses that work in hospitals have...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

